NCT00996788View on ClinicalTrials.gov

Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
DyspepsiaChronic Gastritis
Interventions
DRUG

Rebamipide

Rebamipide 100 mg tid for 28 days

Trial Locations (1)

Unknown

Division of Gastroenterology Department of Internal Medicine - Cipto Mangunkusumo Hospital, Faculty of Medicine University of Indonesia, Jakarta

All Listed Sponsors
lead

PT Otsuka Indonesia

INDUSTRY

NCT00996788 - Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis | Biotech Hunter | Biotech Hunter